SCHEMBL6399736

SCHEMBL6399736

O=C(OC[C@H]1O[C@@H](C(=O)O)[C@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 0.55
▸ POLB P06746 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ PTPN1 P18031 4/20 0.50
▸ CA1 P00915 2/20 0.47
▸ CA2 P00918 2/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ LGALS9 O00182 1/20 0.45
▸ LGALS1 P09382 1/20 0.45
▸ LGALS3 P17931 1/20 0.45
▸ LGALS7; LGALS7B P47929 1/20 0.45
▸ PTPN2 P17706 1/20 0.44
▸ PTPN11 Q06124 1/20 0.44
▸ GAPDH P04406 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MAPK1 P28482 2/20 0.43
▸ TMPRSS2 O15393 1/20 0.43
▸ PDE5A O76074 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2418301 1.00 USP2 (0.55) USP2POLBMEN1KMT2APTPN1
SCHEMBL17975737 1.00 USP2 (0.55) USP2POLBMEN1KMT2APTPN1
SCHEMBL4732553 1.00 USP2 (0.55) USP2POLBMEN1KMT2APTPN1
SCHEMBL11438817 0.89 USP2 (0.53) USP2POLBMEN1KMT2APTPN1
SCHEMBL8946366 0.89 USP2 (0.53) USP2POLBMEN1KMT2APTPN1
SCHEMBL26358941 0.87 USP2 (0.51) USP2POLBMEN1KMT2APTPN1
SCHEMBL6402165 0.87 USP2 (0.51) USP2POLBMEN1KMT2APTPN1
SCHEMBL7152895 0.85 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL17326916 0.84 PTPN1 (0.68) USP2POLBMEN1KMT2APTPN1
SCHEMBL12154605 0.84 PTPN1 (0.68) USP2POLBMEN1KMT2APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009777-A1 Non-natural carbon-linked nucleotides and dinucleotides CELLTECH R & D LIMITED (GB) 2005-01-13 — — US disclosed
EP-1409503-A1 NON-NATURAL CARBON-LINKED NUCLEOTIDES AND DINUCLEOTIDES Celltech R & D Limited (GB) 2004-04-21 — — EP disclosed
WO-2003011885-A1 NON-NATURAL CARBON-LINKED NUCLEOTIDES AND DINUCLEOTIDES CELLTECH R & D LIMITED (GB) 2003-02-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009777-A1 Non-natural carbon-linked nucleotides and dinucleotides P2RY1, P2RY11, P2RY13 USP2 4331/4885POLB 900/4885MEN1 1789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback